PHARMACOECONOMIC EFFICACY OF INCLUSION OF BISMUTH PREPARATIONS IN THE SCHEME OF ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION


A.A. Samsonov (1), D.N. Andreev (1), V.B. Grechushnikov (2)

(1) SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH, Moscow; (2) Central Clinical Hospital № 6 of JSC Russian Railways, Moscow
The article presents the results of evaluation of the efficacy of schemes of treatment of patients with H. Pylori-associated diseases. Quaternary schemes with inclusion of proton pump inhibitor rabeprazole and bismuthatetripotassiumdicitrate allow for a higher eradication rate than the classical triple therapy, and thus improve the clinical efficacy and cost-effectiveness of eradication therapy.

About the Autors


I.V.Maev - SBEI HPE "Moscow State Medical Stomatological University n.a. A.I. Evdokimov", Prof., MD, Head of the Department of Propaedeutics of Internal Diseases and Gastroenterology of the Medical Faculty, Corresponding Member of RAMS, the Hon. Scientist of Russia, Honored. doctor of Russia
A.A. Samsonov - SBEI HPE "Moscow State Medical Stomatological University n.a. A.I. Evdokimov", Prof., MD, Prof. at the Department of Propaedeutics of Internal Diseases and Gastroenterology of the Medical Faculty
D.N. Andreev – Teaching Assistant at the Department of Propaedeutics of Internal Diseases and Gastroenterology MSMSU n.a. A.I. Evdokimov; e-mail: dna-mit8@mail.ru
V.B. Grechushnikov – PhD in Medical Sciences, Head of Endoscopy Unit of the Central Clinical Hospital № 6 of JSC Russian Railways, doctor of the highest qualification category; e-mail: virtor_33307@mail.ru; Grechushnikov271960@yandex.ru


Similar Articles


Бионика Медиа